Testimonials

Usage of cookies

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our privacy policy.

Dynamic ‘cine’ MRI offers a new and potentially powerful perspective on gastrointestinal function, especially in conditions like Crohn’s where hypo-motility is related to disease activity. Objective assessment of this data with GIQuant could represent an important advance in how we quantify this in the clinic

Stuart A Taylor, Consultant Radiologist and Professor of Medical Imaging, UCL

Motilent's technology allows us quantify bowel motility across a range of gastrointestinal diseases. I have used this technology in my research now for several years and we have found it easy to use, allowing us to measure novel parameters from standard MRI examinations for the first time. The research to date is extremely promising and it’s going to be interesting to see how this innovative technology impacts decision making in the clinic

Professor Robin Spiller, University of Nottingham

I have worked together with Alex Menys and the Motilent team for the last 7 years and they have produced innovative software and other features to optimize MRI of the intestine. This has lead to a tool with capacity for groundbreaking research, and based on that they have made several original studies with major impact on our understanding of the physiology and pathophysiology of the digestive function in health and disease. The methods have the potential to facilitate the clinical diagnosis of gastrointestinal diseases, and ultimately this will lead to improved management strategies and better guidelines in patients with a variety of colorectal disorders

Asbjørn Mohr Drewes, Professor and Chief Physician, Director of Mech-Sense and Centre for Pancreatic Diseases, Aalborg University Hospital

Dr Alex Menys

Founder and Chief Executive Officer

Alex founded Motilent in 2013 to expedite collaborative research in his field of medical image analysis for gastrointestinal (GI) disorders. Since then, Motilent has grown to working across a range of GI specialties in research and has produced it’s first clinically available product for Crohn’s disease monitoring – GIQuant. Alex holds master degrees in Biochemistry and Medical Physics, a PhD in MRI imaging and spent 2 years on the board of an AIM listed UK medical device company.

Dr Russell Pearson

Chief Operating Officer

Russell joined Motilent in September 2017 to establish it as a medical device manufacturer to bring GIQuant to the market as a CE marked product. Russell holds an MEng in Biomaterials Engineering, a PhD in Bionanotechnology and 5 years experience of medical device regulations, quality systems and project management.

Laurence Bourn

Chief Technical Officer

Laurence brings a wealth of experience to Motilent working for the past 15 years in medical imaging at some of the most important companies in the space. As CTO, Laurence will help Motilent develop its portfolio of technologies for use in digestive disease and oversee its transition into an ‘at market’ Medical Device company.